Accumulated evidences underscore the importance of the beta-adrenergic receptors and MAPK signaling towards AD pathology [112]; members of these respective networks (ADR-A1D/-B2 and MAPK-8) were altered by FD. The gene discussed is ADRA1D; the disease is Alzheimer disease.